Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated version to v3.0.2 and removed 'Back to Top' link; no substantive changes to core content or critical data.
    Difference
    0.7%
    Check dated 2025-09-13T17:38:42.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-06T15:21:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.
    Difference
    12%
    Check dated 2025-08-30T12:02:40.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:42:04.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:58:07.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous version 2.16.8 has been removed. Additionally, a service alert regarding planned maintenance has been deleted.
    Difference
    4%
    Check dated 2025-08-01T19:32:25.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.